Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence

The use of sodium-glucose co-transporter 2 inhibitors to treat heart failure with preserved ejection fraction (HFpEF) is under investigation in ongoing clinical trials, but the exact mechanism of action is unclear. Here we aimed to use artificial intelligence (AI) to characterize the mechanism of ac...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Sci Rep
Asıl Yazarlar: Bayes-Genis, Antoni, Iborra-Egea, Oriol, Spitaleri, Giosafat, Domingo, Mar, Revuelta-López, Elena, Codina, Pau, Cediel, Germán, Santiago-Vacas, Evelyn, Cserkóová, Adriana, Pascual-Figal, Domingo, Núñez, Julio, Lupón, Josep
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8187349/
https://ncbi.nlm.nih.gov/pubmed/34103605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-91546-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller